Tag: Cancer
-
Accelerating Cancer Immunology and Immunotherapy Research
The Cancer Immunology and Immunotherapy Initiative at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University is bringing together Feinberg investigators who study immunotherapy to increase collaboration and accelerate high-impact immunotherapy research.
-
Understanding Immunosuppressive Mechanisms of T-Cell Receptors
Investigators have discovered the mechanisms underlying a T-cell receptor’s immunosuppressive function, findings that may improve the development of precision therapeutics for chronic disease, including cancer.
-
Gradishar Receives 2022 Rodger Winn Award
William Gradishar, MD, chief of Hematology and Oncology in the Department of Medicine and deputy director of the clinical network of the Lurie Cancer Center, has received the 2022 Rodger Winn Award from the National Comprehensive Cancer Network.
-
Blood Test Predicts Response to Immunotherapy
A blood-based tumor biomarker can predict the benefit of immunotherapy to patients with non-small cell lung cancer.
-
Study Identifies New Therapeutic Target for Most Common Type of Pancreatic Cancer
Northwestern Medicine investigators have discovered a potential therapeutic target for the most common type of pancreatic cancer, according to a study published in Developmental Cell.
-
Recurring Brain Tumor Growth is Halted with New Drug
A new study has identified a drug that inhibits growth of aggressive meningiomas and how to most accurately identify which tumors will respond to the drug.
-
New Regulator of Therapy Resistance in Prostate Cancer
Northwestern Medicine investigators have identified a gene that confers resistance to a common prostate cancer treatment, according to a study published in Cancer Research.
-
New Regulator of Prostate Cancer Metastasis Discovered
A transcription factor associated with androgen receptor activity in prostate cancer has a newly discovered role in controlling lipid biosynthesis.
-
Identifying Mechanisms of Methylation in Stem Cells
Northwestern Medicine scientists identified critical regulatory processes that govern differentiation in embryonic stem cells.
-
Regulator of Cancer ‘Stemness’ Discovered
The protein FOXK2 promotes survival of cancer stem cells in ovarian cancer, according to a Northwestern Medicine study.
